Product Access Program

To learn more, call
1-844-SRCHLGT (1-844-772-4548)

We're here for you and your patients

Searchlight Support® provides education and assistance for people who receive RADICAVA® (edaravone) and those who care for them. Our Care Coordinators are ready to help.

Get forms and resources to order RADICAVA® for your patients >

For Healthcare Providers
For Your Practice

Benefit and eligibility verification, general coding and billing information, and morea

Benefit Investigation and Enrollment

Help with ordering RADICAVA® and enrolling patients in Searchlight Support®

aEach healthcare provider is ultimately responsible for determining the appropriate codes, coverage, and payment for individual patients. Searchlight Support® does not guarantee third-party coverage or payment for RADICAVA® or reimburse for claims that are denied by third-party payers.

For Patients
Cost Support Options
Out-of-Pocket Cost Support Options

Help obtaining co-pay assistance, if eligible

Infusion Center Directory
Infusion Center Directory

Help finding an infusion site of care

For Your Practice

Searchlight Support® can help you and your office staff navigate product access challenges.

We can provide:

  • Rapid benefit investigation and verification of benefits and limited prior authorization assistance
  • Payer policy research for efficient claims submission
  • General coding and billing information for RADICAVA®
  • Assistance with the exceptions and appeals process
  • Training for product handling and administration

Restrictions apply. See Terms and Conditions.

For questions or more information, you can or call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

Benefit Investigation and Enrollment

To order RADICAVA® and conduct a benefit investigation for your patients, you will need to complete and submit a Benefit Investigation and Enrollment Form. In addition to ordering RADICAVA® and starting the benefit investigation process, this form can also enroll your patients in the Searchlight Support® program.b

Complete and submit a BIF

You will need to complete and sign the BIF and obtain the patient's signature. Patients may have already completed Sections 1-4 as suggested on the patient website.

  • Download a BIF using the button below
  • Provide all required information
  • Make sure the patient has read and signed the Patient Authorization in Section 3
  • Fax or mail to Searchlight Support®
    Fax: 1-888-782-6157      Mail: PO Box 2930, Phoenix, AZ 85062

For detailed information on completing the BIF, view the Completing the BIF Video. It will guide you through each section of the BIF, and includes a discussion on how you can use the BIF to define a treatment plan for your patient based on preferred infusion site(s).

NOTE: The information you enter in the BIF is not being stored, so make sure you save it.

Coming Soon

For assistance or additional information, call 1-844-SRCHLGT (1-844-772-4548), Monday-Friday, 8AM-8PM.

Searchlight Support® willc:
  • Acknowledge receipt of Benefit Investigation and Enrollment Form within 1 business day
  • Advise if a prior authorization is required, provide a concise benefit summary to your office and your patient, and offer limited prior authorization and appeals assistance within 2 business days
  • Offer streamlined product acquisition options through Buy & Bill (through our Limited Distribution Network) or specialty pharmacies (including assignment of medical benefit)
Let your patients know

After the enrollment process is complete, a Care Coordinator from Searchlight Support® will be assigned and can call your patients to help with:

bSearchlight Support® cannot enroll a patient in Searchlight Support® services without patient authorization, which can be found on the Benefit Investigation and Enrollment Form, or a separate signed Patient Authorization Form for RADICAVA® on file. In addition, a Searchlight Support® Benefit Investigation and Enrollment Form must be submitted for each patient for whom treatment with RADICAVA® is requested.

cFollowing receipt of a completed Benefit Investigation and Enrollment Form including all required information.

Restrictions apply. See Terms and Conditions.

For questions or more information, you can or call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

Out-of-Pocket Cost Support Options

Searchlight Support® can help you and your patients navigate options that may be available to help cover applicable out-of-pocket costs associated with RADICAVA®, if they are eligible.

 Out-of-Pocket Assistance Program

The Affordability Options Flashcard is a convenient tool you can use with your patients.

Out-of-Pocket Assistance Program
Support for eligible patients with commercial insurance

Patients with commercial insurance coverage for treatment with RADICAVA® may be eligible.

What eligible patients can expect

  • Savings on their deductible, co-pay, and co-insurance costs for their medication and infusion costs for RADICAVA®
  • Applicable out-of-pocket costs are covered—up to $20,000 per calendar year
  • Patients will be automatically re-enrolled for the next calendar year, if eligible

To share information about the Out-of-Pocket Assistance Program with your patients, please download the Out-of-Pocket Assistance Program brochure for patients. This information is also available on the patient website.

Submitting a claim for reimbursement

Once you have received the primary Explanation of Benefits (EOB) from your patient’s insurance provider, you can submit a claim to the Searchlight Support® Out-of-Pocket Assistance Program. To receive reimbursement, download and follow these instructions.

eThe Searchlight Support® Out-of-Pocket Assistance Program is for eligible patients who have commercial insurance that covers a portion of the medication and administration costs for RADICAVA®.

Restrictions apply. See Eligibility Requirements & Terms and Conditions.

Enrolling your patients

How patients get started in the Program

The prescriber completes and submits the Benefit Investigation and Enrollment Form. Eligible patients are automatically enrolled in the Program. Patients may also enroll by completing the Out-of-Pocket Assistance Program Enrollment Form, available in the patient brochure and online at Searchlight Support® will:

  • Verify the patient’s commercial insurance benefits to confirm their eligibility
  • Call the patient to explain their insurance benefits for treatment with RADICAVA® and let them know they are automatically enrolled in the Program
  • Send the patient a welcome letter and brochure with a program card

Remind patients to always bring the program card to their treatment appointments

At the time of treatment

Patients will provide their program card which contains the information required for submission of request for co-payment assistance.

If the infusion provider cannot or does not participate in the Program, or if the patient has already paid for treatment with RADICAVA®, patients may submit a claim with a Request for Out-of-Pocket Assistance Form by mail to Searchlight Support®, 2250 Perimeter Park Drive, Suite 200, Morrisville, NC 27560, or fax to 1-844-695-9284.

Submitting a request for co-payment assistance

First, send a claim for medication and infusion costs to the patient’s primary health plan. Then, complete a secondary claim request for co-payment assistance and submit it to the Program.


Submit a standard electronic claim to Interactive Medical Systems using Payer ID 56155, Group 00003635, and the patient’s Member ID as a secondary payer.


Submit a medical claim form (CMS-1500 or UB-04) and a copy of the primary health plan Explanation of Benefits (EOB).
Mail: PO Box 1349, Wake Forest, NC 27588      Fax: 1-919-562-0021

If submitting a request by fax, please use the Request for Co-payment Assistance Fax Cover Sheet.

Claim Requirements

Make sure all required procedure and drug codes are clearly stated for treatment with RADICAVA®. Please include contact information in case there are any questions about the submission.

Payment for applicable out-of-pocket costs will be issued promptly following validation of all required out-of-pocket claim information. You will receive reimbursement for approved out-of-pocket assistance claims the same way you receive primary insurance payments.

The Program will not provide patient reimbursement above the Wholesale Acquisition Cost (WAC) price.

Please note that claims must be submitted within 365 days of the date listed on the EOB received from the patient’s primary insurance company. View complete instructions for submitting a claim for reimbursement.

If RADICAVA® is obtained under the patient’s pharmacy benefit

Submit a request for co-payment assistance for out-of-pocket infusion administration costs as outlined above, including the EOB and the payer invoice. Co-pay funds are not available until the primary payer EOB is submitted as noted above. The patient will submit a claim for out-of-pocket medication costs to the Program.

For help processing a request for co-payment assistance, call 1-844-772-4548.

Resources for patients who are uninsured

The Searchlight Support® Patient Assistance Program (PAP) can help patients in financial need who are uninsured. Patients who meet Program requirements may be able to receive medication at no charge for up to 2 years.f The patient must be a citizen or a permanent resident of the US or its territories, and reside in the US or its territories. The patient's income must not exceed 5 times the Federal Poverty Level based on household size (Federal Poverty Level Guidelines are available at

To share this information with your patients, please download the Patient Assistance Program Brochure. This information is also available on the patient website.

fOnly product provided at no charge. The Patient Assistance Program covers only the cost of RADICAVA® and not the cost of any infusion services or healthcare provider visits, which are the sole responsibility of the patient.

Restrictions apply. See Eligibility Requirements & Terms and Conditions.

Enrolling your patients
  1. Complete the Benefit Investigation and Enrollment Form and submit to Searchlight Support® with all required documentation.
  2. If a patient meets the Patient Assistance Program requirements, the program will cover their RADICAVA® medication as prescribed by you at no charge for 1 year.g
  3. Patients must reconfirm their eligibility for continued participation in the program after the initial 12-month eligibility period by providing required financial documentation.
  4. If a patient continues to meet the program requirements, they may be able to receive RADICAVA® at no charge for an additional 12 months.

gOnly the product provided at no charge. The Patient Assistance Program covers only the cost of RADICAVA® and not the cost of any infusion services or healthcare provider visits, which are the sole responsibility of the patient.

Alternative coverage research

Searchlight Support® can help research alternative coverage options, as well as provide information about independent, charitable organizations that may be able to provide financial support.h

hCharitable foundations and other third-party patient support organizations are independent from Mitsubishi Tanabe Pharma America, Inc. Each third-party organization has its own eligibility criteria and evaluation process, and Mitsubishi Tanabe Pharma America, Inc. cannot guarantee that patients will receive assistance.

2020 Open Enrollment Information for Patients

The 2020 Open Enrollment Information for Patients brochure is designed to help patients understand coverage options, even if infusion treatments are received at multiple locations, such as your office, infusion centers, a hospital outpatient department, or their homes. During Open Enrollment, patients can review their insurance coverage and make changes, or they can choose new plans. Since this brochure does not include a complete list of health plan options, patients should contact their health insurance companies or go to for specific information.

To learn more, download the 2020 Open Enrollment Information for Patients brochure. If you or your patients have questions, please call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

Infusion Center Directory

For your patients who receive RADICAVA® outside of their home, Searchlight Support® can help find an infusion site of care from our National Infusion Center Directory based on:

  • Where patients live and their insurance
  • The centers' hours of operation

For more information about adding your site of care to our National Infusion Center Directory, call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548) or go to the Infusion Center Enrollment page.

Try the ALS Care Locator

See how patients can find a healthcare provider, including those who have prescribed RADICAVA®.

Take a Look

Searchlight Support® FAQs

Who can use Searchlight Support®?

To help navigate access to treatment with RADICAVA®, Searchlight Support® offers product access programs for healthcare providers and people who receive RADICAVA®. Caregivers may also seek support on behalf of a loved one who receives RADICAVA®.

For questions about the services available for your patients and your practice, call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

Does Searchlight Support® offer product access support options for RADICAVA® for veterans with ALS?

No. However, the Department of Veterans Affairs (VA) provides assistance and access to treatment options for veterans with ALS. This includes treatment with RADICAVA®, which is on the VA National Formulary with a national prior authorization. You can learn more about these services and accessing RADICAVA® for veterans here.

Can you send a representative to my office?

Yes. To arrange for a Rep to come to your office, sign up to request a visit.

How can I start ordering RADICAVA®?

At Searchlight Support®, we offer tools and services to help you navigate access to treatment for your patients.

Is product training available?

Yes. A representative from Searchlight Support® can visit your practice to show you how to properly store and administer RADICAVA®.

To request a visit, you can sign up or call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

These topics are also discussed in the Administration Guide video.

How can I tell if product has been exposed to oxygen and is unusable?

When you remove RADICAVA® from the carton, you will notice that the IV bags are protected by a secondary overwrap packaging that contains an oxygen absorber and an oxygen indicator. You should only use RADICAVA® if the indicator is pink prior to opening the overwrap packaging. This reflects appropriate oxygen levels.

However, if the indicator is blue or purple before the overwrap is opened, it means that the product was exposed to oxygen and should not be used.

For more information, watch the Administration Guide video or call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

How do I return damaged or unused product?

To return damaged or unused product, contact Return Goods Customer Service at 1-844-529-8990.

For other product-related questions, call Searchlight Support® at 1-844-SRCHLGT (1-844-772-4548).

Review the Return Goods Policy >

To learn more, call 1-844-SRCHLGT (1-844-772-4548).

Important Safety Information

Hypersensitivity Reactions

Radicava® (edaravone) is contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in Radicava®. Hypersensitivity reactions (redness, wheals, and erythema multiforme) and cases of anaphylaxis (urticaria, decreased blood pressure, and dyspnea) have been reported. Patients should be monitored carefully for hypersensitivity reactions, and if they occur, discontinue Radicava®, treat per standard of care, and monitor until the condition resolves.

Sulfite Allergic Reactions

Radicava® contains sodium bisulfite, and may cause allergic type reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown, but occurs more frequently in asthmatic people.

Most Common Adverse Reactions

Most common adverse reactions (at least 10% and greater than placebo) are contusion, gait disturbance, and headache.


Based on animal data, Radicava® may cause fetal harm.

Geriatric Use

No overall differences in safety or effectiveness were observed between patients 65 years of age and older and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

To report suspected adverse reactions or product complaints, contact Mitsubishi Tanabe Pharma America, Inc., at 1-888-292-0058. You may also report suspected adverse reactions to the FDA at 1-800-FDA-1088 or


Radicava® is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Please see full Prescribing Information.

For more information about RADICAVA®, call 1-888-292-0058.